Smith Graham & Co Investment Advisors’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-403,049
Closed -$10.6M 135
2017
Q2
$10.6M Sell
403,049
-21,940
-5% -$539K 1.15% 15
2017
Q1
$9.95M Sell
424,989
-8,020
-2% -$198K 1.06% 20
2016
Q4
$10.9M Buy
433,009
+72,800
+20% +$1.84M 1.18% 16
2016
Q3
$10.1M Buy
360,209
+10,510
+3% +$269K 1.29% 5
2016
Q2
$8.62M Sell
349,699
-22,470
-6% -$558K 1.19% 9
2016
Q1
$8.23M Buy
372,169
+60,910
+20% +$1.62M 1.07% 18
2015
Q4
$10.9M Sell
311,259
-9,000
-3% -$282K 1.55% 1
2015
Q3
$9.12M Sell
320,259
-670
-0.2% -$22.5K 1.33% 8
2015
Q2
$10.7M Sell
320,929
-142,531
-31% -$4.38M 1.44% 8
2015
Q1
$13.1M Sell
463,460
-570
-0.1% -$14.2K 1.77% 3
2014
Q4
$9.61M Sell
464,030
-28,630
-6% -$680K 1.37% 7
2014
Q3
$12M Sell
492,660
-13,880
-3% -$368K 1.78% 2
2014
Q2
$14.5M Sell
506,540
-19,510
-4% -$543K 2.01% 1
2014
Q1
$14.7M Sell
526,050
-111,460
-17% -$2.74M 2.13% 1
2013
Q4
$13.7M Sell
637,510
-1,560
-0.2% -$28.4K 1.94% 1
2013
Q3
$8.48M Buy
639,070
+97,587
+18% +$1.31M 1.23% 12
2013
Q2
$7.5M Buy
+541,483
New +$7.67M 1.16% 21

Other funds holding PMC

Smith Graham & Co Investment Advisors's PMC Position: Q3 2017 in Review

Smith Graham & Co Investment Advisors sold out of PharMerica Corporation (PMC) in Q3 2017, closing a stake of 403,049 shares — an estimated $10.6M sold.

Smith Graham & Co Investment Advisors first reported a position in PMC in Q2 2013 and held it in 17 quarters. The position peaked at $14.7M in Q1 2014. 150 funds tracked by Wall St. Rank hold PMC as of Q3 2017.

  • Smith Graham & Co Investment Advisors reported no remaining PharMerica Corporation position as of Q3 2017 after selling out during the quarter.
  • Smith Graham & Co Investment Advisors sold 403,049 PharMerica Corporation shares in Q3 2017, an estimated $10.6M.
  • Smith Graham & Co Investment Advisors first reported a position in PharMerica Corporation in Q2 2013 and held it in 17 quarters.
  • Smith Graham & Co Investment Advisors's PharMerica Corporation position peaked at $14.7M in Q1 2014.
  • 150 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2017.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q3 2017, filed 19 Oct 2017.